Precision Medicine Articles | Today's Clinical Lab

Our findings suggest that mRNA vaccines may provide just the spark the immune system needs to turn “cold” tumors “hot.”

COVID-19 mRNA Vaccines Could Unlock the Next Revolution in Cancer Treatment—New Research

Christiano Marconi, Adam Grippin, MD, PhD

With a little help, your immune cells can be potent tumor killers

NGS-based assays are now considered standard for optimal treatment planning in many tumor types.

Rapid In-House NGS Is Closing the Gap in Precision Cancer Therapy

Luca Quagliata, PhD, BCMAS, COA

Automated NGS reduces complexity and cost, enabling community hospitals to expand testing without major infrastructure investments

The ability of 3D printing to make precisely shaped objects in a wide range of materials has led to, for example, custom replacement joints and custom-dosage, multidrug pills.

How 3D Printing Is Personalizing Health Care

Anne Schmitz, PhD, Daniel Freedman, PhD

Exploring the lab-driven innovations behind custom implants, drug delivery, and diagnostic tools

Despite the alarming statistics, many sepsis-related deaths are preventable through rapid diagnosis and treatment.

Challenges and Advances in Sepsis Detection

Zahraa Chorghay, PhD

FDA-approved tests like Intellisep and TriVerity™ demonstrate potential for early sepsis diagnosis

Unfortunately, notable roadblocks and disparities can limit access or extend the time it takes to get a cancer diagnosis.

Smarter Screening, Sooner: The Role of Diagnostic Innovation in Early Cancer Detection

Michael D. Lutz, MD

How are new diagnostic tools changing cancer screening?

For this study, Caris's AI model analyzed data from over 35,000 patients in the Caris clinico-genomic database.

AI Outperforms Traditional Biomarkers in Predicting Breast Cancer Immunotherapy Success

Caris Life Sciences

New study in Nature Communications highlights AI's role in transforming immunotherapy decisions and precision oncology

MosaiQ AiPlex® Vasculitis assay, now available for clinical use in the European Union and other CE mark accepting countries.

New Multiplex Assay Aims to Accelerate Diagnosis of Autoimmune Vasculitis

AliveDx

A new CE-marked test for MPO, PR3, and anti-GBM autoantibodies offers faster, simplified serological evaluation and may help labs streamline workflows in vasculitis testing

“The ADLM 2025 program spotlights the sweeping scope of laboratory medicine in solving the most pressing problems of our time,” said ADLM CEO Mark J. Golden.

ADLM 2025 to Address Medical Misinformation, Health Risks Posed by Plastics, AI Integration into Care, Precision Medicine, and More

Association for Diagnostics and Laboratory Medicine

This year’s meeting, in partnership with CSCC, explores clinical AI, medical misinformation, plastics in health, and advances in genomics and microbiome medicine

Caris built on the findings from the study and analyzed 3,255 matched tumor–blood NGS samples from its extensive real-world clinico-genomic database of over 500,000 samples.

Precision Oncology Findings Stress Importance of Identifying TI-CH in Lab Reports

Caris Life Sciences

Findings underscore the importance of matched tumor–blood sequencing to avoid diagnostic errors in oncology

Traditional quality assurance programs focus only on analytical accuracy, leaving a gap in ensuring that the results are precise and actionable for patient care. The Molecular EQA program goes beyond just accuracy to also evaluate report clarity, how quickly results are delivered, and the result interpretation.

The Future of Pathology: Integrating Molecular EQA for Improved Cancer Care

Sofia Ramirez

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice

Survey Insights on Pathology's Transformation to AI and Precision Medicine from Laboratory Leadership

Today's Clinical Lab

Join Today's Clinical Lab and speakers Nathan Buchbinder, Dr. Bilal R. Ahmad, Dr. Derek Welch, and Dr. Brian Rubin as they discuss survey insights on pathology’s transformation to AI and precision medicine

In 2025, many of the most promising trials center innovations in precision diagnostics, genetic testing, and computational modeling, especially in high-need areas like rare diseases and oncology.

Top 5 Clinical Trials Shaping Medicine in 2025

Zahraa Chorghay, PhD

From precision oncology to gene editing, these standout trials could redefine how we diagnose and treat rare diseases and cancer

Hologic to Present New Data at ASCO 2025 on the Breast Cancer Index® Test’s Role in Personalized Care

Hologic

Assessment of over 2,800 patients highlights the profound impact of the BCI test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer

Today's Clinical Lab 2025 Cancer & Precision Medicine print issue

'The Critical Role of the Clinical Lab'

Miriam Bergeret, MSc

The Today's Clinical Lab 2025 Cancer & Precision Medicine print issue features cancer screening successes, emerging technologies, and advances in targeted treatments

The Covaris truCOVER WGS PCR-free Library Prep Kit enhances the efficiency and quality of library preparation for whole genome sequencing of multiple sample types.

Emerging Technologies Guide: April 2025

Today's Clinical Lab

Recent new and emerging technologies in the field of laboratory medicine from the 2025 April Cancer & Precision Medicine issue of Today's Clinical Lab

Illustration of an abstract retro circular burst design representing eyesight and the structure of human eye.

Gene Therapies for Retinal Diseases Head to Clinical Trials

Jennifer Welsh

Inherited retinal diseases cause vision loss and blindness. New gene therapy trials have improved sight for some

Illustration of a DNA helix molecule with DNA base pairs ready for epigenome editing.

Rewiring Biological Time and Aging with Epigenome Editing

Charles A. Gersbach, PhD

The bright, new future of therapeutic epigenome editing is already on our doorstep

Illustration of two CAR T-cells attacking a cancer cell.

Researchers Move Toward Off-the-Shelf CAR T-Cell Therapy for Cancer

Today's Clinical Lab

New breakthrough from Memorial Sloan Kettering Cancer Center shows how off-the-shelf CAR T cells from healthy donors can be modified to fight cancer without immune rejection